Loading Events

Thank You For Attending Today’s Webinar

Please tell us what you thought about today’s presentation by taking the survey below:

Unmet Needs In Agitation Associated With Alzheimer’s Dementia (AAD)

This is a virtual event for PsychU members in Kansas, Missouri, Nebraska, Iowa, South Dakota and Illinois.

This evidence-based review highlights important aspects of agitation associated with Alzheimer’s Dementia (AAD) for better understanding of the prevalence and challenges in diagnosis and explore the potential pathobiological correlations in AAD. Describes the clinical and humanistic burden and discusses current guidelines for nonpharmacological and pharmacological treatments of this complex and prominent complication of an already devastating disease. It underlines unmet needs for FDA-approved pharmaceutical treatments for agitation to improve care and quality of life for patients suffering from AAD.

Featuring

Clayton-Levret

Clayton Levret, PharmD

Medical Science Liaison

More
Clayton Levret received his PharmD from the University of Kansas. Post-graduation Clayton worked as a clinical pharmacist prior to joining the Otsuka FMA team.
Maria-Perez

Maria Perez, PharmD, AAHIVP

Medical Science Liaison – Digital Therapeutics

Speakers Clayton Levret, PharmD and Maria Perez, PharmD, AAHIVP are employees of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC)

Registration

Related Resources